Obsidian Therapeutics, Inc. (OBX)
11.24
+1.64
(+17.08%)
USD |
NASDAQ |
Nov 06, 10:17
Obsidian Therapeutics Shareholders Equity (Quarterly) : 30.32M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 30.32M |
| March 31, 2026 | 5.023M |
| December 31, 2025 | 6.551M |
| September 30, 2025 | -146.64M |
| June 30, 2025 | -145.35M |
| March 31, 2025 | -144.36M |
| December 31, 2024 | -143.67M |
| September 30, 2024 | -143.06M |
| June 30, 2024 | -138.03M |
| March 31, 2024 | -134.69M |
| December 31, 2023 | -131.18M |
| September 30, 2023 | -126.55M |
| June 30, 2023 | -115.00M |
| March 31, 2023 | -97.61M |
| Date | Value |
|---|---|
| December 31, 2022 | -109.18M |
| September 30, 2022 | -97.50M |
| June 30, 2022 | -83.25M |
| March 31, 2022 | -70.47M |
| December 31, 2021 | -58.00M |
| September 30, 2021 | -43.17M |
| June 30, 2021 | -25.52M |
| March 31, 2021 | -10.57M |
| December 31, 2020 | 6.118M |
| September 30, 2020 | 24.70M |
| June 30, 2020 | 40.24M |
| March 31, 2020 | 53.06M |
| December 31, 2019 | 69.61M |
| September 30, 2019 | 27.46M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Cypherpunk Technologies, Inc. | 139.32M |
| Cue Biopharma, Inc. | 2.31M |
| Yarrow Bioscience, Inc. | 22.06M |
| Faeth Therapeutics, Inc. | 167.86M |
| Immuneering Corp. | 168.68M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 51.44M |
| Total Liabilities (Quarterly) | 21.12M |
| Debt to Equity Ratio | 0.0959 |
| Current Ratio | 2.296 |